State-of-the-Art Review on RV Long Strain w/ clinical and prognostic relevance, practical guide & essential tips for clinical use in #EHJCVI
Honored to work w/ @KristinaHaugaa @DonalErwan @Ivan_Echocardio JU Voigt @s_e_petersen @bogdan_popescu1 T Marwick
doi.org/10.1093/ehjci/โฆ
Denisa Muraru
6,485 posts
#EACVI President-Elect | Cardiologist specialized in #cvimaging | Head of Heart Valve Clinic @TwittAuxologico | Assoc. Prof @unimib l FESC FACC FASE |
Milan, Italy
Born April 3
Joined August 2011
- Our state of the art article on atrial secondary #tricuspid regurgitation from the #PCRTricuspid Focus Group has been listed among the most cited articles published in the #EHJ in the past 12 months. Grateful to the co-authors and to my colleagues from @TwittAuxologico for this
- Tricuspid regurgitation: what have we learnt? #EHJCVI ๐ฉ New nomenclature ๐ฉ New classification ๐ฉ New grading ๐ฉ New imaging approaches doi.org/10.1093/ehjci/โฆ Fantastic leadership by @hahn_rt &collaboration @lpbadano @drmaisano @pe_bartko @DonalErwan JL Zamorano #PCRTricuspid
- Right Heart, Right Now: The Role of #3DEcho authors.elsevier.com/a/1fLEA3BS3sTPโฆ Grateful to my mentors, research fellows and colleagues for their support and to @ASE360 for this unique opportunity authors.elsevier.com/a/1fLEA3BS3sTPโฆ @lpbadano @mikepicardmd @robertomlang @hahn_rt @bogdan_popescu1
- LA reservoir and contractile strain by #echofirst adds incremental prognostic value for pts with AL or ATTR amyloid cardiomyopathy. In absence of AF, prophylactic anticoagulation should be considered if LA reservoir strain is <6.4% or contractile strain is <2.4% @AllanLKleinMD1
- HOW to use and WHEN to use transesophageal #3DEcho in clinical practice ๐Beautiful EACVI consensus document in #EHJCVI doi.org/10.1093/ehjci/โฆ @EACVIPresident @GeraldMaurer @NAjmoneMarsan @DonalErwan @Cosyns @ThorEdvardsen @Sarah_Moharem @hahn_rt @robertomlang
- The year in cardiovascular medicine 2023: the top 10 papers in valvular heart disease @ESC_Journals #VHD
- LV crypts were described as subtle sign of #HCM. Largest study to date (>10,000) by #YesCCT showed: - 9% frequency in Danish general population - NO relation with โฌ๏ธMACE at 4y FU - โฌ๏ธfrequency with young age, low BP & hard exercise doi.org/10.1093/ehjci/โฆ @GeraldMaurer #EHJCVI
- Mavacamten: a first-in-class myosin inhibitor for obstructive hypertrophic cardiomyopathy academic.oup.com/eurheartj/artiโฆ Donโt miss this fantastic state-of-the-art review in #EHJ by Eugene Braunwald et al. #HOCM #cvimaging #echofirst #whyCMR #EACVI
- NEW practical guide in #EHJCVI: ๐ How to quantify coronary atherosclerotic plaque by #YesCCT Find out the tips from #EACVI experts @gpontone1 @MarcDweck @PalMaurovich doi.org/10.1093/ehjci/โฆ @GeraldMaurer @ESC_Journals @escardio @EACVIPresident @s_e_petersen
- Wonderful review in #JASE on cardiac anatomy by Dr Faletra and how using 3D echo helps one to better understand 2D echo anatomy. Highly recommended paper for cardiac imagers #EACVI #CVImaging #echofirst @escardio
- Left atrial mass in 76 y/o pt with no history of CV disease #echofirst #cvimaging #EACVI #3Decho @3DEcho360 @escardio
00:00 - Finally in printโฆ Grateful to my colleagues from the #EACVI Research&Innovation committee 2020-2022, Steffen Petersen, and Cosyns Bernard, for their support and valuable contribution to this document doi.org/10.1093/ehjci/โฆ @EACVIPresident @VDelgadoGarcia @Sarah_Moharem
- With the first woman President, Dr Victoria Delgado, a new mandate in the #EACVI journey is just starting. I feel honored to have the opportunity to work, learn and get inspired by the fantastic personalities of @VDelgadoGarcia and EACVI Past President @s_e_petersen in the next


























